Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Brain Ischemia D002545 89 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Hyperlipidemias D006949 73 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Parkinson Disease D010300 53 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Precancerous Conditions D011230 48 associated lipids
Leukemia P388 D007941 43 associated lipids
Occupational Diseases D009784 42 associated lipids
Hypotension D007022 41 associated lipids
Adenoma D000236 40 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Heart Failure D006333 36 associated lipids
Epilepsy D004827 35 associated lipids
Hyperplasia D006965 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Liver Diseases D008107 31 associated lipids
Kidney Diseases D007674 29 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Hyperinsulinism D006946 27 associated lipids
Alcoholism D000437 27 associated lipids
Anemia D000740 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Critical Illness D016638 13 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Hypocalcemia D006996 12 associated lipids
Hepatitis D006505 11 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Monsénégo J et al. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. 2012 J. Hepatol. pmid:22037024
Ozkurt S et al. Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients. 2012 Ren Fail pmid:22017464
Toblli JE et al. Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model. 2012 Inflamm Allergy Drug Targets pmid:22309085
Stachowska-Pietka J et al. Computer simulations of osmotic ultrafiltration and small-solute transport in peritoneal dialysis: a spatially distributed approach. 2012 Am. J. Physiol. Renal Physiol. pmid:22301624
Muñoz M et al. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. 2012 Br J Anaesth pmid:22337966
Freburger JK et al. Changing patterns of anemia management in US hemodialysis patients. 2012 Am. J. Med. pmid:22938926
Christoph P et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. 2012 J Perinat Med pmid:22945271
Rostoker G et al. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study. 2012 Am. J. Med. pmid:22998881
Okam MM et al. Comparative rates of adverse events with different formulations of intravenous iron. 2012 Am. J. Hematol. pmid:22965928
Borchard G et al. Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies. 2012 Regul. Toxicol. Pharmacol. pmid:22951348
Ceretta LB et al. Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats. 2012 Exp Diabetes Res pmid:22645603
Yamamoto S et al. Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide. 2012 Intern. Med. pmid:22975552
Bidossi A et al. A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. 2012 PLoS ONE pmid:22428019
Galutira PJ and Del Rio M Understanding renal posttransplantation anemia in the pediatric population. 2012 Pediatr. Nephrol. pmid:22086345
Ernst MC et al. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. 2012 Endocrinology pmid:22186410
Walters KR et al. Methamphetamine causes anorexia in Drosophila melanogaster, exhausting metabolic reserves and contributing to mortality. 2012 J Toxicol Sci pmid:22863857
Bespalov VG and Aleksandrov VA [Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors]. 2012 Vopr Onkol pmid:23607211
Araki T et al. Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iron deficiency anemia. 2012 Pharmazie pmid:23346769
Lê BV et al. Modulation of Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation by chronic iron overload in rat. 2012 FEMS Immunol. Med. Microbiol. pmid:22066700
Smith TN et al. Modifications in the nitric acid oxidation of D-glucose. 2012 Carbohydr. Res. pmid:22285512
Kowalczyk M et al. Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease. 2011 Nov-Dec J. Nephrol. pmid:21956770
Bhattacharya S et al. Prophylactic role of D-Saccharic acid-1,4-lactone in tertiary butyl hydroperoxide induced cytotoxicity and cell death of murine hepatocytes via mitochondria-dependent pathways. 2011 Nov-Dec J. Biochem. Mol. Toxicol. pmid:21538728
Adhikary L and Acharya S Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. 2011 Jul-Sep JNMA J Nepal Med Assoc pmid:22922860
Moorani KN and Asim S Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease. 2011 Jul-Sep J Ayub Med Coll Abbottabad pmid:23272434
Yetman AT and Everitt MD The role of iron deficiency in protein-losing enteropathy following the Fontan procedure. 2011 Jul-Aug Congenit Heart Dis pmid:21392262
Walther J et al. Hot transcriptomics. 2011 Archaea pmid:21350598
Denton TT et al. Characterization of D-glucaric acid using NMR, X-ray crystal structure, and MM3 molecular modeling analyses. 2011 Carbohydr. Res. pmid:22015400
Bhattacharya S et al. D-saccharic acid-1,4-lactone ameliorates alloxan-induced diabetes mellitus and oxidative stress in rats through inhibiting pancreatic β-cells from apoptosis via mitochondrial dependent pathway. 2011 Toxicol. Appl. Pharmacol. pmid:21982801
Aspuru K et al. Optimal management of iron deficiency anemia due to poor dietary intake. 2011 Int J Gen Med pmid:22114518
Di Nocera PP et al. Genome organization of epidemic Acinetobacter baumannii strains. 2011 BMC Microbiol. pmid:21985032
Lv YK et al. Poly[dimethyl-ammonium [aquadi-μ(2)-oxalato-yttriate(III)] trihydrate]. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21836844
Lv YK et al. Poly[dimethyl-ammonium [aquadi-μ(2)-oxalato-samarate(III)] trihydrate]. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21836843
Toyokuni S Mysterious link between iron overload and CDKN2A/2B. 2011 J Clin Biochem Nutr pmid:21297911
Nasir A et al. Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi. 2011 J Pak Med Assoc pmid:22356035
Wada Y et al. [Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide]. 2011 Nippon Naika Gakkai Zasshi pmid:22175146
Lawrence MC et al. Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. 2011 J. Biol. Chem. pmid:21059644
Agarwal R et al. Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial. 2011 Clin J Am Soc Nephrol pmid:20876669
Auerbach M Should intravenous iron be upfront therapy for iron deficiency anemia? 2011 Pediatr Blood Cancer pmid:21298731
Crary SE et al. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. 2011 Pediatr Blood Cancer pmid:21298748
Ibert M et al. Evidence of benzilic rearrangement during the electrochemical oxidation of D-glucose to D-glucaric acid. 2011 Carbohydr. Res. pmid:21269605
Vanderford NL The role of MafA in regulating cytokine expression in pancreatic beta cells. 2011 J. Biol. Chem. pmid:21239506
Fenwick S and Peebles G Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis. 2011 J Ren Care pmid:21288317
Pai AB et al. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. 2011 Biometals pmid:21229380
Krafft A and Breymann C Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. 2011 J. Obstet. Gynaecol. Res. pmid:21159035
Stefánsson BV et al. Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran. 2011 Nephron Clin Pract pmid:21196770
Atalay H et al. Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients. 2011 Hemodial Int pmid:21564503
Malovrh M et al. The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents. 2011 Artif Organs pmid:20618233
Rottembourg J et al. Do two intravenous iron sucrose preparations have the same efficacy? 2011 Nephrol. Dial. Transplant. pmid:21355067
Kim Y et al. Combination of erythritol and fructose increases gastrointestinal symptoms in healthy adults. 2011 Nutr Res pmid:22118754
Ruiz JC et al. Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. 2011 PLoS ONE pmid:21533164